The Searle Company Limited (SEARL)

PHARMACEUTICALSACIALLSHRKMI30KMIALLSHRKSE100KSE100PRKSE30MII30

88.78

+1.13%

As of 25-Aug-2026

52 Week RangeCurrent: 88.78

76.37137.44

Updated: 25-Aug-2026

1M+0.4%

3M-1.7%

1Y-9.3%

3Y+162.5%

5Y-28.3%

Valuation Snapshot

Review how the market has valued this company across price multiples.

Updated through 21-Aug-2026

P/E

41.16x

P/B

1.46x

P/S

1.43x

EV/Sales

6.04x

EV/EBITDA

37.12x

Showing 37 observations

Annual Ratio Highlights

Metric	2021	2022	2023	2024	2025
EPS	12.15	5.79	0.78	-4.96	-2.73
DPS	0.72	0.00	0.00	0.00	0.00
BVPS	44.35	52.18	53.85	58.56	55.92
PER	7.22x	15.14x	112.40x	-17.68x	-32.11x
Div Yield	1.35%	0.00%	0.00%	0.00%	0.00%
PBV	1.98	1.68	1.63	1.50	1.57
EV/Sales	2.22x	2.00x	2.74x	2.19x	2.06x
Price/Sales	1.56x	1.37x	2.00x	1.75x	1.80x
EV/EBITDA	9.82x	9.57x	16.29x	12.10x	13.66x
EV/Gross Profit	4.78x	4.55x	6.26x	4.70x	4.20x

Metric	2021	2022	2023	2024	2025
Gross Margin	46.50%	43.89%	43.84%	46.62%	49.20%
EBITDA Margin	22.61%	20.88%	16.85%	18.10%	15.12%
Operating Margin	20.82%	18.88%	14.05%	15.09%	11.77%
Pretax Margin	19.20%	12.24%	1.16%	4.65%	5.57%
Net Margin	14.29%	8.08%	1.60%	-8.18%	-4.80%

Metric	2021	2022	2023	2024	2025
ROE	17.50%	8.28%	1.01%	-7.19%	-4.10%
ROA	9.91%	4.49%	0.53%	-3.77%	-2.45%
ROTA	14.71%	10.77%	6.13%	7.04%	5.98%
ROCE	15.16%	13.97%	9.43%	11.57%	10.18%